Andrew Douglas Baxter

Person

Cambridge, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Crystallisation and purification of glycopyrronium bromide
- Patent number 8,846,954
- Issue date Sep 30, 2014
- Sosei R&D Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of beta-aminoalcohols in the treatment of inflammatory disorder...
- Patent number 8,188,150
- Issue date May 29, 2012
- Biocopea Limited
- John Brew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of bupropion metabolites for the treatment of inflammatory diso...
- Patent number 8,030,357
- Issue date Oct 4, 2011
- Biocopea Limited
- John Brew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycopyrronium salts and their therapeutic use
- Patent number 7,915,303
- Issue date Mar 29, 2011
- Sosei R&D Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ester derivatives of rhein and their therapeutic use
- Patent number 7,728,035
- Issue date Jun 1, 2010
- Sosei R&D Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,933,306
- Issue date Aug 23, 2005
- Darwin Discovery Ltd.
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective MMP inhibitors having reduced side-effects
- Patent number 6,818,622
- Issue date Nov 16, 2004
- Darwin Discovery Ltd.
- John Bird
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamic acid derivatives
- Patent number 6,809,100
- Issue date Oct 26, 2004
- Darwin Discovery Ltd.
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic acid derivatives
- Patent number 6,787,536
- Issue date Sep 7, 2004
- Darwin Discovery Limited
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,734,189
- Issue date May 11, 2004
- Darwin Discovery, Ltd.
- Duncan Batty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...
- Patent number 6,706,719
- Issue date Mar 16, 2004
- Darwin Discovery, Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,680,338
- Issue date Jan 20, 2004
- Darwin Discovery Ltd.
- John Gary Montana
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...
- Patent number 6,566,384
- Issue date May 20, 2003
- Darwin Discovery Ltd.
- David Alan Owen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,506,764
- Issue date Jan 14, 2003
- Darwin Discovery, Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,506,773
- Issue date Jan 14, 2003
- Darwin Discovery Ltd.
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,503,910
- Issue date Jan 7, 2003
- Darwin Discovery Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,469,020
- Issue date Oct 22, 2002
- Darwin Discovery, Ltd.
- Duncan Batty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,465,468
- Issue date Oct 15, 2002
- Darwin Discovery Limited
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhib...
- Patent number 6,462,042
- Issue date Oct 8, 2002
- Darwin Discovery Limited
- David Alan Owen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic acid derivatives
- Patent number 6,455,531
- Issue date Sep 24, 2002
- Darwin Discovery, Ltd.
- David Alan Owen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...
- Patent number 6,310,088
- Issue date Oct 30, 2001
- Darwin Discovery, Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...
- Patent number 6,187,924
- Issue date Feb 13, 2001
- Darwin Discovery, Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptidyl compounds
- Patent number 6,180,611
- Issue date Jan 30, 2001
- Darwin Discovery, Ltd.
- John Montana
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...
- Patent number 6,118,001
- Issue date Sep 12, 2000
- Darwin Discovery, Ltd.
- David Alan Owen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptidyl compounds having MMP and TNF inhibitory activity
- Patent number 6,114,372
- Issue date Sep 5, 2000
- Darwin Discovery Limited
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptidyl compounds and their therapeutic use
- Patent number 6,110,896
- Issue date Aug 29, 2000
- Darwin Discovery, Ltd.
- Andrew Douglas Baxter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamic and carboxylic acid derivatives
- Patent number 6,100,266
- Issue date Aug 8, 2000
- Darwin Discovery Limited
- John Gary Montana
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptidyl compounds having MMP and TNF inhibitory activity
- Patent number 6,090,840
- Issue date Jul 18, 2000
- Darwin Discovery Limited
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds having MMP and TNF inhibitory activity
- Patent number 6,063,786
- Issue date May 16, 2000
- Darwin Discovery, Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptidyl compounds
- Patent number 6,048,841
- Issue date Apr 11, 2000
- Darwin Discovery, Ltd.
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders a...
- Publication number 20120219592
- Publication date Aug 30, 2012
- BIOCOPEA LIMITED
- John Brew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Beta-Aminoalcohols for the Treatment of Inflammatory Disorde...
- Publication number 20100016357
- Publication date Jan 21, 2010
- SOSEI R & D LTD.
- Andrew Douglas Baxter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Bupropion Metabolites for the Treatment of Inflammatory Diso...
- Publication number 20090318562
- Publication date Dec 24, 2009
- SOSEI R & D LTD.
- John Brew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Beta-Aminoalcohols in the Treatment of Inflammatory Disorder...
- Publication number 20090306216
- Publication date Dec 10, 2009
- John Brew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound H...
- Publication number 20090270437
- Publication date Oct 29, 2009
- Andrew Douglas Baxter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions for the Treatment of Pruritus
- Publication number 20090093509
- Publication date Apr 9, 2009
- Tahir Nazir
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Glycopyrronium Salts and Their Therapeutic Use
- Publication number 20090062372
- Publication date Mar 5, 2009
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzoxazocines and Their Therapeutic Use
- Publication number 20090012178
- Publication date Jan 8, 2009
- BEMIS MANFACTURING
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Inflammatory Disorders and Pain
- Publication number 20080306162
- Publication date Dec 11, 2008
- Andrew Douglas Baxter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dihydroxyanthraquinones and Their Use
- Publication number 20080234258
- Publication date Sep 25, 2008
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystallisation and Purification of Glycopyrronium Bromide
- Publication number 20080227988
- Publication date Sep 18, 2008
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Inflammatory Disorders and Pain
- Publication number 20080096971
- Publication date Apr 24, 2008
- Andrew Douglas Baxter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ester derivatives of rhein and their therapeutic use
- Publication number 20070185036
- Publication date Aug 9, 2007
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of inflammatory disorders and pain using beta-aminoalcohols
- Publication number 20070179181
- Publication date Aug 2, 2007
- Andrew Douglas Baxter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystalline forms of (+)- and (-) erythro-mefloquine hydrochloride
- Publication number 20070078161
- Publication date Apr 5, 2007
- Kenneth Walter Sinden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of ifenprodril in the treatment of pain
- Publication number 20070043111
- Publication date Feb 22, 2007
- John Brew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of non-opiates for the potentation of opiates
- Publication number 20070043112
- Publication date Feb 22, 2007
- John Brew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Resolution of mefloquine with o,o-di-p-aroyltartaric acid
- Publication number 20060111573
- Publication date May 25, 2006
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel benzoxazocines and their therapeutic use
- Publication number 20060019940
- Publication date Jan 26, 2006
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic acid derivatives
- Publication number 20040266764
- Publication date Dec 30, 2004
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic and carboxylic acid derivatives
- Publication number 20040176362
- Publication date Sep 9, 2004
- Duncan Batty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic and carboxylic acid derivatives
- Publication number 20040127717
- Publication date Jul 1, 2004
- John Gary Montana
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES
- Publication number 20030236416
- Publication date Dec 25, 2003
- John Gary Montana
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic acid derivatives
- Publication number 20030216404
- Publication date Nov 20, 2003
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...
- Publication number 20030207889
- Publication date Nov 6, 2003
- David Alan Owen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic and carboxylic acid derivatives
- Publication number 20030092727
- Publication date May 15, 2003
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic and carboxylic acid derivatives
- Publication number 20030032652
- Publication date Feb 13, 2003
- Duncan Batty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic and carboxylic acid derivatives
- Publication number 20030022893
- Publication date Jan 30, 2003
- Andrew Douglas Baxter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic acid derivatives
- Publication number 20020037900
- Publication date Mar 28, 2002
- Duncan Robert Hannah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective MMP inhibitors having reduced side-effects
- Publication number 20020035065
- Publication date Mar 21, 2002
- John Bird
- C07 - ORGANIC CHEMISTRY

Andrew Douglas Baxter

Person

Patents Grantslast 30 patents

Crystallisation and purification of glycopyrronium bromide

Use of beta-aminoalcohols in the treatment of inflammatory disorder...

Use of bupropion metabolites for the treatment of inflammatory diso...

Glycopyrronium salts and their therapeutic use

Ester derivatives of rhein and their therapeutic use

Hydroxamic and carboxylic acid derivatives

Selective MMP inhibitors having reduced side-effects

Hydroxamic acid derivatives

Hydroxamic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhib...

Hydroxamic acid derivatives

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...

Peptidyl compounds

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...

Peptidyl compounds having MMP and TNF inhibitory activity

Peptidyl compounds and their therapeutic use

Hydroxamic and carboxylic acid derivatives

Peptidyl compounds having MMP and TNF inhibitory activity

Heterocyclic compounds having MMP and TNF inhibitory activity

Peptidyl compounds

Patents Applicationslast 30 patents

Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders a...

Use of Beta-Aminoalcohols for the Treatment of Inflammatory Disorde...

Use of Bupropion Metabolites for the Treatment of Inflammatory Diso...

Use of Beta-Aminoalcohols in the Treatment of Inflammatory Disorder...

Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound H...

Methods and Compositions for the Treatment of Pruritus

Glycopyrronium Salts and Their Therapeutic Use

Benzoxazocines and Their Therapeutic Use

Treatment of Inflammatory Disorders and Pain

Dihydroxyanthraquinones and Their Use

Crystallisation and Purification of Glycopyrronium Bromide

Treatment of Inflammatory Disorders and Pain

Ester derivatives of rhein and their therapeutic use

Treatment of inflammatory disorders and pain using beta-aminoalcohols

Crystalline forms of (+)- and (-) erythro-mefloquine hydrochloride

Use of ifenprodril in the treatment of pain

Use of non-opiates for the potentation of opiates

Resolution of mefloquine with o,o-di-p-aroyltartaric acid

Novel benzoxazocines and their therapeutic use

Hydroxamic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives

HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES

Hydroxamic acid derivatives

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhib...

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic and carboxylic acid derivatives

Hydroxamic acid derivatives

Selective MMP inhibitors having reduced side-effects